Democrats push for stem cell vote in US Senate
By Reuters,
Reuters
| 05. 04. 2006
WASHINGTON (Reuters) - Senate Democrats sought on Thursday to jump-start a long-awaited debate on legislation to allow federal funding of embryonic stem cell research by considering it while it debates other health measures this month.
The Democrats sent a letter to Majority Leader Bill Frist asking him to add stem cells to what Republicans have dubbed "health week." Frist wants the Senate to consider other health legislation, possibly next week, on medical malpractice and small business insurance.
Despite a veto threat by President George W. Bush, the U.S. House of Representatives passed a bipartisan bill last year backing research on excess embryos that would otherwise be discarded by fertility clinics.
The Senate has not taken up the bill, Frist, a Tennessee Republican, broke with other conservatives to embrace it in a surprise move last summer.
"Further delay will mean more lost opportunities for new cures and new treatments," leading Democrats said in a letter to Frist to be made public on Thursday.
The letter to Frist from Senate Democratic leader Harry Reid of Nevada, stem cell bill co-sponsor Tom Harkin...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...